Literature DB >> 15297107

A prospective cohort study of feeding needle catheter jejunostomy in an upper gastrointestinal surgical unit.

Kin-Fah Chin1, Sara Townsend, Wingzou Wong, Glenn V Miller.   

Abstract

BACKGROUND & AIM: Feeding jejunostomy is recommended to facilitate early enteral nutrition after major upper gastrointestinal surgery. We aimed to determine the benefits and risks associated with routine practice of feeding needle catheter jejunostomy (NCJ) in high-risk upper gastrointestinal surgery.
METHOD: This is a prospective consecutive cohort study of 84 patients underwent feeding NCJ over a 3 years period in an Upper Gastrointestinal Surgical Unit.
RESULTS: Feeding NCJ was placed after two-stage oesophago-gastrectomy in 24 patients (28.6%), after gastrectomy in 29 patients (34.5%), after liver resections in 7 patients (8.3%), pancreatic resection in 6 patients (7.1%), bile duct reconstruction in 8 patients (9.5%) and other operations in 10 patients (12%). The mean (SE) estimated nutritional requirement per 24 h was 1791 (31)kcal. Eighty-two patients (98%) started enteral feed on day 1 after surgery. Fifty-seven patients (68%) achieved the target nutritional requirements in 3 days. Four patients were discharged home on jejunal feed whilst only two patients required parenteral nutrition support. The rest tolerated full oral diet. There was no procedure related mortality. The morbidity related to feeding tube and feeding were 12.9% and 20%, respectively.
CONCLUSIONS: Routine practice of feeding NCJ is safe. Their benefits outweigh the risks in a specialist centre. Copyright 2003 Elsevier Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15297107     DOI: 10.1016/j.clnu.2003.11.002

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  1 in total

1.  Unusual complication of multiple splenic abscesses arising from a feeding jejunostomy tube subsequent to total gastrectomy: A case report and literature review.

Authors:  Shuchang An; Bing Li; Rong Cui; Feng Yan; Guoshan Yang; L I Zhao; Zhenya Zhang; Ruiqin Wang
Journal:  Oncol Lett       Date:  2015-03-03       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.